Prostate Cell News Volume 14.13 | Apr 14 2023

    0
    25








    2023-04-14 | PCN 14.13


    Prostate Cell News by STEMCELL Technologies
    Vol. 14.13 – 14 April, 2023
    TOP STORY

    Targeting Advanced Prostate Cancer with STEAP1 Chimeric Antigen Receptor T Cell and Tumor-Localized IL-12 Immunotherapy

    The authors reported broad expression of STEAP1 relative to prostate-specific membrane antigen in lethal metastatic prostate cancers and the development of a STEAP1-directed chimeric antigen receptor T cell therapy.
    [Nature Communications]

    Full Article
    New human primary cancer-sourced blood products, immune cell subsets, and more. Click to view products.
    PUBLICATIONSRanked by the impact factor of the journal

    Autocrine Activation of MAPK Signaling Mediates Intrinsic Tolerance to Androgen Deprivation in LY6D Prostate Cancer Cells

    Investigators demonstrated that conditional deletion of PTEN in the murine prostate epithelium caused an expansion of transformed LY6D+ progenitor cells without impairing stem cell properties.
    [Cell Reports]

    Full ArticleGraphical Abstract

    PIM1 Phosphorylates ABI2 to Enhance Actin Dynamics and Promote Tumor Invasion

    Scientists identified a novel signaling pathway linking hypoxia and Proviral Integration site for Moloney murine leukemia virus (PIM) 1 kinase to the actin cytoskeleton and cell motility.
    [Journal of Cell Biology]

    Full Article

    VSSP-Activated Macrophages Mediate Senescence and Tumor Inhibition in a Preclinical Model of Advanced Prostate Cancer

    The authors found that very small size particles (VSSP) decreased tumor-associated macrophages and inhibited prostatic tumor growth when administered to castrated Pten-deficient prostate tumor-bearing mice.
    [Cell Communication and Signaling]

    Full ArticleGraphical Abstract

    Targeting SMYD2 Inhibits Prostate Cancer Cell Growth by Regulating c-Myc Signaling

    SMYD2 knockdown cells were established to identify the effects of SMYD2 on prostate cancer cell growth in vitro and in vivo.
    [Molecular Carcinogenesis]

    Abstract

    Novel Roles for HMGA2 Isoforms in Regulating Oxidative Stress and Sensitizing to RSL3-Induced Ferroptosis in Prostate Cancer Cells

    Scientists analyzed the expression of wild-type vs. truncated high mobility group A2 (HMGA2) and showed that prostate cancer patient tissue and some cell lines expressed increasing amounts of both wild-type and truncated HMGA2 with increasing tumor grade.
    [Heliyon]

    Full Article

    Long Noncoding RNA GHET1 Promotes Cell Proliferation through Oxidative Stress in Prostate Cancer

    The authors investigated the mechanism by which long noncoding RNA GHET1 promoted prostate cancer cell proliferation and related metabolism.
    [Journal of Biochemical and Molecular Toxicology]

    Abstract

    Flavonoid Brachydin B Decreases Viability, Proliferation, and Migration in Human Metastatic Prostate (DU145) Cells Grown in 2D and 3D Culture Models

    Researchers evaluated the effects of the brachydin B flavonoid on cell viability, proliferation, and migration/invasion of metastatic prostate cells cultured both as traditional 2D monolayers and 3D tumor spheroids in vitro.
    [Toxicology Research]

    Abstract
    Graphical Abstract

    Metabolic Shift towards Oxidative Phosphorylation Reduces Cell-Density-Induced Cancer-Stem-Cell-Like Characteristics in Prostate Cancer In Vitro

    Scientists measured the expression levels of glycolysis and OXPHOS-related genes and performed spheroid forming, cell viability, and various glycolysis to investigate the Warburg effect and cancer stem cell-like characteristics in prostate cancer.
    [Biology Open]

    Full Article
    Submit your best cell image to the #StemCellfie contest!
    REVIEWS

    A Comprehensive Review on the Molecular Basis and Therapeutic Targets in Prostate Cancer

    Investigators summarize the pathophysiological mechanisms and available targeted therapies for clinically actionable markers in prostate cancer.
    [Biomolecules & Biomedicine]

    Abstract
    INDUSTRY AND POLICY NEWS

    LLU Researchers Awarded over $5.8 Million in Grants from National Institutes of Health

    Loma Linda University (LLU) School of Medicine researchers received over $5.8 million in grants from the National Institutes of Health.
    [Loma Linda University School of Medicine]

    Press Release
    FEATURED EVENT

    IABCR 2023: 32nd International Association for Breast Cancer Research Conference

    May 1 – 4, 2022
    Riviera Maya, Mexico

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Research Associate – Head and Neck Cancer

    University of Liverpool – Liverpool, England, United Kingdom

    Faculty Positions – Cancer Research

    Case Western Reserve University – Cleveland, Ohio, United States

    Postdoctoral Fellow – Bioinformatics

    The University of British Columbia – Vancouver, British Columbia, Canada

    Postdoctoral Fellow – Prostate Cancer Translational Research

    The University of Miami – Miami, Florida, United States

    Specialist – StainsFile

    STEMCELL Technologies, Inc. – Vancouver, British Columbia, Canada

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Prostate Cell News Twitter